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A medium sized Oncology textbook such as this one poses the
question ‘What is it for?’, since it is too big for the pocket, but
necessarily abbreviated compared with the weighty comprehensive
tomes. The authors state that they have primarily aimed ‘Oncology’
at undergraduate medical students, but also hope to serve nursing
and para-medical staff, junior hospital doctors, general practi-
tioners and hospice staff. However, what the undergraduate
craves is simplicity and clarity, while what the practitioner encoun-
ters is the complexity of clinical diagnosis and treatment.
‘Oncology’ is arranged in a standard format with principles of
cancer biology and treatment followed by particular organ system
sections. Palliative and psychological care receive an early mention
while oncological emergencies arrive at the end. The multiple
authors around a nucleus of Belfast-based clinicians have adopted
a consistent style that is clear and attractive with colour highlights
to text boxes and tables. Each chapter concludes with illustrative
case studies and references, although the latter suffer from textbook
delay and are seldom more recent than 1998.
I found this book worked best as an undergraduate text provid-
ing a broad overview of each area. It is often clear and concise for
the student audience, but rather short on the evidence for the
treatments described.
Throughout the book prognostic statements are provided as
summary ﬁgures for per cent 5-year or 10-year survival, which
have the beneﬁt of simplicity, but do not provide the full picture.
Indeed this book must be unique amongst oncology texts in not
displaying a single survival graph and in the process loses much
of the information on the heterogeneity of patient and disease
behaviour. There is very little discussion on how to interpret cancer
trials and evaluate the evidence that they provide and no discussion
about how to assess relative risk and beneﬁt so that patients can be
counselled appropriately.
Neither could I ﬁnd any discussion on how to present the
options and choices in a patient friendly manner that enabled
the patient to participate in his or her treatment decisions, or
the inﬂuence of the patient’s performance status and quality of life
in any of the treatment recommendations. I missed the sense of
excitement that recent developments have injected into topics such
as screening and genetic testing, apoptosis and chemotherapy/
radiotherapy, targeted monoclonal antibody therapy, synchronous
chemo and radiotherapy for squamous cancers of the head and
neck, oesophageal, cervical and anal regions, or the newer opioid
analgesics, such as Fentanyl in palliative care.
The classiﬁcation of chemotherapeutic agents is rather idiosyn-
cratic (e.g.; topoisomerase inhibitors), while under thoracic
tumours, the aggregation of small cell lung cancers with carcinoids,
while pathologically logical, made for therapeutic confusion.
Oncology has rapidly come of age in the past ten years and
some of the history needs to be consigned to the archives; such
as Halstead’s radical mastectomy (p. 418) and the need for radio-
therapists to exercise ‘full and exclusive responsibility like the
surgeon’ (p. 139). The new age is complicated by the need to
continually reassess complex and changing information and to
include our patients in their treatment decisions. This oncology
text provides a sound review for the undergraduate, but is missing
much that the practitioner would ﬁnd necessary for their future
practice.
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